Page 18 - Read Online
P. 18

van Wiechen et al. Mini-invasive Surg 2022;6:1  https://dx.doi.org/10.20517/2574-1225.2021.96  Page 11 of 11

               6.       Durko AP, Osnabrugge RL, Van Mieghem NM, et al. Annual number of candidates for transcatheter aortic valve implantation per
                   country: current estimates and future projections. Eur Heart J 2018;39:2635-42.  DOI  PubMed
               7.       Vemulapalli S, Carroll JD, Mack MJ, et al. Procedural volume and outcomes for transcatheter aortic-valve replacement. N Engl J Med
                   2019;380:2541-50.  DOI  PubMed
               8.       Lauck SB, Wood DA, Baumbusch J, et al. Vancouver transcatheter aortic valve replacement clinical pathway: minimalist approach,
                   standardized care, and discharge criteria to reduce length of stay. Circ Cardiovasc Qual Outcomes 2016;9:312-21.  DOI  PubMed
               9.       Wood DA, Lauck SB, Cairns JA, et al. The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical pathway
                   facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement
                   centers: The 3M TAVR Study. JACC Cardiovasc Interv 2019;12:459-69.  DOI  PubMed
               10.      Barbanti M, van Mourik MS, Spence MS, et al. Optimising patient discharge management after transfemoral transcatheter aortic valve
                   implantation: the multicentre European FAST-TAVI trial. EuroIntervention 2019;15:147-54.  DOI  PubMed
               11.      Abdel-Wahab M, Mehilli J, Frerker C, et al; CHOICE investigators. Comparison of balloon-expandable vs self-expandable valves in
                   patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 2014;311:1503-14.  DOI
                   PubMed
               12.      Toggweiler S, Nissen H, Mogensen B, et al. Very low pacemaker rate following ACURATE neo transcatheter heart valve
                   implantation. EuroIntervention 2017;13:1273-80.  DOI  PubMed
               13.      Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the
                   Valve Academic Research Consortium-2 consensus document. Eur Heart J 2012;33:2403-18.  DOI  PubMed
               14.      Wayangankar SA, Elgendy IY, Xiang Q, et al. Length of stay after transfemoral transcatheter aortic valve replacement: an analysis of
                   the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. JACC Cardiovasc Interv
                   2019;12:422-30.  DOI  PubMed
               15.      Dall'Ara G, Eltchaninoff H, Moat N, et al; Transcatheter Valve Treatment Sentinel Registry (TCVT) Investigators of the
                   EurObservational Research Programme (EORP) of the European Society of Cardiology. Local and general anaesthesia do not
                   influence outcome of transfemoral aortic valve implantation. Int J Cardiol 2014;177:448-54.  DOI  PubMed
               16.      Ehret C, Rossaint R, Foldenauer AC, et al. Is local anaesthesia a favourable approach for transcatheter aortic valve implantation? BMJ
                   Open 2017;7:e016321.  DOI  PubMed  PMC
               17.      Saint S, Greene MT, Kowalski CP, Watson SR, Hofer TP, Krein SL. Preventing catheter-associated urinary tract infection in the
                   United States: a national comparative study. JAMA Intern Med 2013;173:874-9.  DOI  PubMed  PMC
               18.      Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device
                   during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J 2015;36:2070-8.  DOI  PubMed
               19.      Nombela-Franco L, del Trigo M, Morrison-Polo G, et al. Incidence, causes, and predictors of early (≤30 days) and late unplanned
                   hospital readmissions after transcatheter aortic valve replacement. JACC Cardiovasc Interv 2015;8:1748-57.  DOI  PubMed
               20.      Kolte D, Khera S, Sardar MR, et al. Thirty-day readmissions after transcatheter aortic valve replacement in the United States: insights
                   from the nationwide readmissions database. Circ Cardiovasc Interv 2017;10:e004472.  DOI  PubMed
               21.      van der Boon RM, Nuis RJ, Benitez LM, et al. Frequency, determinants and prognostic implications of infectious complications after
                   transcatheter aortic valve implantation. Am J Cardiol 2013;112:104-10.  DOI  PubMed
               22.      Tirado-Conte G, Freitas-Ferraz AB, Nombela-Franco L, et al. Incidence, causes, and impact of in-hospital infections after transcatheter
                   aortic valve implantation. Am J Cardiol 2016;118:403-9.  DOI  PubMed
               23.      Ream K, Sandhu A, Valle J, et al. Ambulatory rhythm monitoring to detect late high-grade atrioventricular block following
                   transcatheter aortic valve replacement. J Am Coll Cardiol 2019;73:2538-47.  DOI  PubMed
               24.      Tang GHL, Zaid S, Michev I, et al. “Cusp-overlap” view simplifies fluoroscopy-guided implantation of self-expanding valve in
                   transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018;11:1663-5.  DOI  PubMed
   13   14   15   16   17   18   19   20   21   22   23